Catherine Alix-Panabières, Director of the Laboratory of Rare Human Circulating Cells, shared a post by Front Line Genomics on LinkedIn, adding:
“Delighted to share that I will be presenting our latest data during Webinar 2: Beyond ctDNA – Evaluating the Next Generation of Liquid Biopsy Biomarkers on 23 July 2026.
It will be a pleasure to join my colleague Anne Hallermann also part of the European Liquid Biopsy Society Admin community to highlight the growing impact of Liquid Biopsy and discuss the exciting opportunities emerging beyond ctDNA.
Looking forward to sharing our work and exchanging ideas with colleagues from across the field of precision oncology.
23 July 2026 / 3pm BST / 4pm CEST / 10am EST.”
Quoting Front Line Genomics’s post:
“If you’re interested in how liquid biopsy is moving from research into clinical practice, then don’t miss Liquid Biopsy online – From Assay to Clinical Adoption, a three-part webinar series.
Join leading researchers, clinicians and industry experts and explore the journey from assay design and biomarker development through to clinical trials and clinical adoption, as they examine the full translational pathway and the key factors that will determine clinical implementation.
Webinar 1: Designing Liquid Biopsy Assays for Real-World Use
Thursday 16th July 2026 at 3pm BST / 4pm CEST / 10am EST
Sponsored by Twist Bioscience
Talk 1: Implementing Liquid Biopsy in Paediatric Oncology: Balancing Breadth, Cost, and Clinical Utility
Alexandre Rouette, Clinical Specialist, CHU Sainte-Justine Children’s Hospital
Talk 2: Customizable Genomic Profiling of Cell-Free DNA for Oncology
James Flynn, Senior Staff Product Manager, Twist Bioscience
Talk 3: Evaluating Whole Blood as an Alternative to Plasma for Liquid Biopsy Applications
Maria Neofytou, Lecturer, University of Westminster
Webinar 2: Beyond ctDNA – Evaluating the Next Generation of Liquid Biopsy Biomarkers
Thursday 23rd July 2026 at 3pm BST/ 4pm CEST/ 10am EST
Sponsored by Thermo Fisher Scientific
Talk 1: Rethinking Liquid Biopsy: From Targeted Panels to Multimodal Detection
Ariane H., Head of Research and Development, Medical Genetics Centre
Talk 2: Expanding the Role of CTCs and Immune Cells in Cancer Detection and Monitoring
Catherine Alix-Panabières, Professor of Oncology and Director of the Laboratory of Rare Human Circulating Cells, University of Montpellier
Talk 3: Enhancing Signal Detection in Multi-Omic Spatial Analysis for Early Cancer Insights
Dineika Chandrananda, Senior Bioinformatics Research Officer, Peter MacCallum Cancer Centre
Webinar 3: From Trials to Routine Care: Making Liquid Biopsy Work in Practice
Thursday 30th July 2026 at 3pm BST/ 4pm CEST/ 10am EST
Panellists
- Dan Stetson, Director of Translational Genomics, Astra Zeneca
- Magda Meissner, Clinical Liquid Biopsy Lead, All Wales Medical Genomics Services
- Florent Mouliere, Team Lead, National Biomarker Centre, CRUK Manchester Institute
All these webinars are interactive sessions, so come armed with questions.
Register now to join the discussion: link in comments!”
Other articles featuring Catherine Alix-Panabières on OncoDaily.